MAB3315
Anti-MMP-7 Antibody, clone 141-7B2
clone 141-7B2, Chemicon®, from mouse
Synonym(s):
Matrilysin
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
clone
141-7B2, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Specificity
The antibody specifically reacts with precursor form of human MMP-7. Does not cross-react with the active forms of human MMP-7 and human MMP-1, 2, 3, 8, 9 and 13.
Immunogen
Rectal carcinoma (SW837) cells.
Application
Anti-MMP-7 Antibody, clone 141-7B2 is an antibody against MMP-7 for use in ELISA, WB, IH(P).
Immunoblotting: 10 μg/mL Molecular weight band around 30kDa.
Immunohistochemistry on paraffin-embedded tissue sections: 4-20 μg/mL
EIA
Optimal working dilutions must be determined by end user.
Immunohistochemistry on paraffin-embedded tissue sections: 4-20 μg/mL
EIA
Optimal working dilutions must be determined by end user.
Research Category
Cell Structure
Cell Structure
Research Sub Category
MMPs & TIMPs
MMPs & TIMPs
Physical form
Format: Purified
Purified immunoglobulin. Liquid in 0.1 M sodium phosphate buffer, pH 7.0 containing 2% protease-free bovine serum albumin.
Storage and Stability
Maintain at -20°C in undiluted aliquots for up to 12 months from date of receipt. Avoid repeated freeze/thaw cycles.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Manufactured by Daiichi Fine Chemical Co., Ltd
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway.
Chen, YJ; Lee, LY; Chao, YK; Chang, JT; Lu, YC; Li, HF; Chiu, CC; Li, YC; Li, YL; Chiou et al.
Testing null
Yali Zhai et al.
The American journal of pathology, 160(4), 1229-1238 (2002-04-12)
In various cancers, inactivating mutations in the adenomatous polyposis coli or Axin tumor suppressor proteins or activating mutations in beta-catenin's amino-terminal domain elevate beta-catenin levels, resulting in marked effects on T-cell factor (TCF)-regulated transcription. Several candidate beta-catenin/TCF-regulated genes in cancer
Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
Fernanda Roca, Laura V Mauro, Ana Morandi, Fernando Bonadeo, Carlos Vaccaro et al.
Journal of Surgical Oncology null
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara, F, et al.
Journal of Neuropathology and Experimental Neurology, 57, 839-849 (1998)
Anna Kerola et al.
The journal of pathology. Clinical research, 2(3), 187-198 (2016-08-09)
The molecular mechanisms underlying progressive liver fibrosis following surgical treatment of biliary atresia (BA) remain unclear. Our aim was to address hepatic gene and protein expression and serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) after successful
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service